Cargando…

Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study

BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seibold, Max A., Moore, Camille M., Everman, Jamie L., Williams, Blake J.M., Nolin, James D., Fairbanks-Mahnke, Ana, Plender, Elizabeth G., Patel, Bhavika B., Arbes, Samuel J., Bacharier, Leonard B., Bendixsen, Casper G., Calatroni, Agustin, Camargo, Carlos A., Dupont, William D., Furuta, Glenn T., Gebretsadik, Tebeb, Gruchalla, Rebecca S., Gupta, Ruchi S., Khurana Hershey, Gurjit K., Murrison, Liza Bronner, Jackson, Daniel J., Johnson, Christine C., Kattan, Meyer, Liu, Andrew H., Lussier, Stephanie J., O’Connor, George T., Rivera-Spoljaric, Katherine, Phipatanakul, Wanda, Rothenberg, Marc E., Seroogy, Christine M., Teach, Stephen J., Zoratti, Edward M., Togias, Alkis, Fulkerson, Patricia C., Hartert, Tina V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/
https://www.ncbi.nlm.nih.gov/pubmed/35660376
http://dx.doi.org/10.1016/j.jaci.2022.05.014
_version_ 1784718188201639936
author Seibold, Max A.
Moore, Camille M.
Everman, Jamie L.
Williams, Blake J.M.
Nolin, James D.
Fairbanks-Mahnke, Ana
Plender, Elizabeth G.
Patel, Bhavika B.
Arbes, Samuel J.
Bacharier, Leonard B.
Bendixsen, Casper G.
Calatroni, Agustin
Camargo, Carlos A.
Dupont, William D.
Furuta, Glenn T.
Gebretsadik, Tebeb
Gruchalla, Rebecca S.
Gupta, Ruchi S.
Khurana Hershey, Gurjit K.
Murrison, Liza Bronner
Jackson, Daniel J.
Johnson, Christine C.
Kattan, Meyer
Liu, Andrew H.
Lussier, Stephanie J.
O’Connor, George T.
Rivera-Spoljaric, Katherine
Phipatanakul, Wanda
Rothenberg, Marc E.
Seroogy, Christine M.
Teach, Stephen J.
Zoratti, Edward M.
Togias, Alkis
Fulkerson, Patricia C.
Hartert, Tina V.
author_facet Seibold, Max A.
Moore, Camille M.
Everman, Jamie L.
Williams, Blake J.M.
Nolin, James D.
Fairbanks-Mahnke, Ana
Plender, Elizabeth G.
Patel, Bhavika B.
Arbes, Samuel J.
Bacharier, Leonard B.
Bendixsen, Casper G.
Calatroni, Agustin
Camargo, Carlos A.
Dupont, William D.
Furuta, Glenn T.
Gebretsadik, Tebeb
Gruchalla, Rebecca S.
Gupta, Ruchi S.
Khurana Hershey, Gurjit K.
Murrison, Liza Bronner
Jackson, Daniel J.
Johnson, Christine C.
Kattan, Meyer
Liu, Andrew H.
Lussier, Stephanie J.
O’Connor, George T.
Rivera-Spoljaric, Katherine
Phipatanakul, Wanda
Rothenberg, Marc E.
Seroogy, Christine M.
Teach, Stephen J.
Zoratti, Edward M.
Togias, Alkis
Fulkerson, Patricia C.
Hartert, Tina V.
author_sort Seibold, Max A.
collection PubMed
description BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission. METHODS: For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses. RESULTS: In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04). CONCLUSION: Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection.
format Online
Article
Text
id pubmed-9155183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-91551832022-06-02 Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study Seibold, Max A. Moore, Camille M. Everman, Jamie L. Williams, Blake J.M. Nolin, James D. Fairbanks-Mahnke, Ana Plender, Elizabeth G. Patel, Bhavika B. Arbes, Samuel J. Bacharier, Leonard B. Bendixsen, Casper G. Calatroni, Agustin Camargo, Carlos A. Dupont, William D. Furuta, Glenn T. Gebretsadik, Tebeb Gruchalla, Rebecca S. Gupta, Ruchi S. Khurana Hershey, Gurjit K. Murrison, Liza Bronner Jackson, Daniel J. Johnson, Christine C. Kattan, Meyer Liu, Andrew H. Lussier, Stephanie J. O’Connor, George T. Rivera-Spoljaric, Katherine Phipatanakul, Wanda Rothenberg, Marc E. Seroogy, Christine M. Teach, Stephen J. Zoratti, Edward M. Togias, Alkis Fulkerson, Patricia C. Hartert, Tina V. J Allergy Clin Immunol Covid-19 BACKGROUND: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. OBJECTIVE: Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission. METHODS: For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses. RESULTS: In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04). CONCLUSION: Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2022-08 2022-06-01 /pmc/articles/PMC9155183/ /pubmed/35660376 http://dx.doi.org/10.1016/j.jaci.2022.05.014 Text en © 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Seibold, Max A.
Moore, Camille M.
Everman, Jamie L.
Williams, Blake J.M.
Nolin, James D.
Fairbanks-Mahnke, Ana
Plender, Elizabeth G.
Patel, Bhavika B.
Arbes, Samuel J.
Bacharier, Leonard B.
Bendixsen, Casper G.
Calatroni, Agustin
Camargo, Carlos A.
Dupont, William D.
Furuta, Glenn T.
Gebretsadik, Tebeb
Gruchalla, Rebecca S.
Gupta, Ruchi S.
Khurana Hershey, Gurjit K.
Murrison, Liza Bronner
Jackson, Daniel J.
Johnson, Christine C.
Kattan, Meyer
Liu, Andrew H.
Lussier, Stephanie J.
O’Connor, George T.
Rivera-Spoljaric, Katherine
Phipatanakul, Wanda
Rothenberg, Marc E.
Seroogy, Christine M.
Teach, Stephen J.
Zoratti, Edward M.
Togias, Alkis
Fulkerson, Patricia C.
Hartert, Tina V.
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title_full Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title_fullStr Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title_full_unstemmed Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title_short Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study
title_sort risk factors for sars-cov-2 infection and transmission in households with children with asthma and allergy: a prospective surveillance study
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/
https://www.ncbi.nlm.nih.gov/pubmed/35660376
http://dx.doi.org/10.1016/j.jaci.2022.05.014
work_keys_str_mv AT seiboldmaxa riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT moorecamillem riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT evermanjamiel riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT williamsblakejm riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT nolinjamesd riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT fairbanksmahnkeana riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT plenderelizabethg riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT patelbhavikab riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT arbessamuelj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT bacharierleonardb riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT bendixsencasperg riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT calatroniagustin riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT camargocarlosa riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT dupontwilliamd riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT furutaglennt riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT gebretsadiktebeb riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT gruchallarebeccas riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT guptaruchis riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT khuranahersheygurjitk riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT murrisonlizabronner riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT jacksondanielj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT johnsonchristinec riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT kattanmeyer riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT liuandrewh riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT lussierstephaniej riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT oconnorgeorget riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT riveraspoljarickatherine riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT phipatanakulwanda riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT rothenbergmarce riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT seroogychristinem riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT teachstephenj riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT zorattiedwardm riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT togiasalkis riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT fulkersonpatriciac riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT harterttinav riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy
AT riskfactorsforsarscov2infectionandtransmissioninhouseholdswithchildrenwithasthmaandallergyaprospectivesurveillancestudy